+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The lack of sedative properties of cl 988 a selective cck b receptor antagonist



The lack of sedative properties of cl 988 a selective cck b receptor antagonist



Society for Neuroscience Abstracts 17(1-2): 1493




(PDF emailed within 1 workday: $29.90)

Accession: 033856716

Download citation: RISBibTeXText


Related references

Mizolastine, a novel selective histamine H1 receptor antagonist: lack of sedative potential on the EEG in the rodent. Neuropsychobiology 32(4): 214-221, 1995

Ebastine a new selective histamine h 1 receptor antagonist with antiallergic activity and without sedative effects. Revista de Farmacologia Clinica y Experimental 4(3): 290, 1987

3-Amino-beta-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam. Journal of Medicinal Chemistry 28(6): 824-828, 1985

The anxiolytic but not the sedative properties of tracazolate are reversed by the benzodiazepine receptor antagonist, Ro 15-1788. Neuropsychobiology 14(4): 193-197, 1985

mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties. Journal of Pharmacology and Experimental Therapeutics 349(1): 155-164, 2014

Lack of effect of a selective NK2 receptor antagonist in acute nociceptive tests. Neuropeptides 24(4): 219-0, 1993

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl- D-aspartate receptor antagonist, but (-)-HA-966 is a potent c-butyrolactone-like sedative. Proceedings of the National Academy of Sciences of the United States of America 87(1): 7-51, 1990

Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist. European Journal of Pharmacology 406(3): 345-354, 20 October, 2000

Lack of electrocardiographic effects of Rupatadine, new nonsedating selective histamine H1-receptor and PAF antagonist. Allergy 56(Supplement 68): 200-201, 2001

Lack of acute antipsychotic effect of Sch 23390, a selective dopamine D1 receptor antagonist. Lancet 337(8745): 854-855, 1991

A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents. Journal of Medicinal Chemistry 48(21): 6756-6760, 2005

Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Proceedings of the National Academy of Sciences of the United States of America 87(1): 347-351, 1990

Anti-sedative and anti-cataleptic properties of NCS-382, a gamma-hydroxybutyrate receptor antagonist. European Journal of Pharmacology 203(3): 393-397, 1991

Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19. European Journal of Pharmacology 211(1): 113-116, 1992

Molecular determinants responsible for sedative and non-sedative properties of histamine H₁-receptor antagonists. Journal of Pharmacological Sciences 124(2): 160-168, 2014